Advertisement

Topics

Companies Related to "ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study" [Most Relevant Company Matches] RSS

18:33 EST 19th February 2019 | BioPortfolio

Here are the most relevant search results for "ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study" found in our extensive corporate database of over 50,000 company records.

Showing "Aortic Bioprosthesis Model 1000 Post Approval Study" Companies 1–25 of 2,100+

Relevant

Thubrikar Aortic Valve, Inc.

Thubrikar Aortic Valve, Inc., founded in October 2010, is a privately held medical device company headquartered in Norristown, PA. The Company has developed a low-profile, bovine pericardial, self-expanding percutaneous valve for transcatheter aortic valve implantation (TAVI) - called the “Optimum TAV” - as a treatment option for aortic stenosis. ...


BioStable Science & Engineering, Inc.

BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. The company’s HAART Aortic Repair Technologies are designed to simplify and standardize aortic valve repair, enabling...

Endospan

Privately held Endospan, headquartered in Herzlia (Tel Aviv), Israel, is a pioneer in the endovascular repair of Aortic Arch Disease including aneurysms and dissections. Endospan has initiated the CE-marking regulatory process to market in Europe the NEXUS™ Stent Graft System, the first endovascular off-the-shelf system to treat Aortic Arch Dise...


JenaValve Technology, Inc.

JenaValve Technology, Inc., a U.S. corporation with primary operations in Munich, Germany, develops, manufactures and markets transcatheter aortic valve implantation systems (TAVI) to treat patients suffering from aortic valve disease. JenaValve was founded in 2006 by cardiologists and inventor’s Prof. Hans R. Figulla, M.D. and Prof. Markus Ferrari, M...

Vitrolife AB (publ)

The fourth of the total of twelve patients included in the USA study for STEEN Solution™, and which enables sales approval in the important USA market, has now received a transplant. The first transplantation was carried out in September and four transplantations have thus now been carried out at four centres. A fifth centre, Duke University, has been ...

JenaValve Technology GmbH

JenaValve Technology is a medical device company focused on developing transcatheter-delivered aortic valve systems to treat patients suffering from aortic valve disease. The company develops replacement aortic valve systems for both transapical and transfemoral approaches (TAVI) to address the needs of cardiac surgeons and cardiologists. JenaValve is back...

JC Medical, Inc.

JC Medical, Inc. is a private, venture-backed medical device company transforming the treatment of Aortic Valve Disease, a growing clinical need in the face of the prevalence of heart disease due to a failing aortic valve and an aging population. For more information, visit www.j-valve.com.

B. McLaughlin Associates, Inc.

BMA is a niche provider of clinical research services based in West Chester, Pennsylvania and Phoenix, Arizona. Our services focus on Study Management, Regulatory and Financial Document Retrieval, Clinical Study Agreement/Per Patient Budget Negotiation, Informed Consent Review and Approval, Data Discrepancy Retrieval, and Regulatory Document Audits.

Precision Image Analysis, Inc.

PIA offers healthcare delivery at lower cost while maintaining high standards by freeing physicians and other medical personnel to operate at the top of their license in a delegated model. PIA uses proprietary technology to provide a service for technical post-processing analysis of cMRIs. This helps physicians interpret images more efficiently by shifting...

The Washington Post

The Washington Post provides award-winning news and understanding about the politics, policies, personalities and institutions that make Washington, D.C. the world's seat of power, and is a critical tool and information source for those who call Washington, D.C. home. In digital form, The Washington Post combines its world-class journalism with the latest ...

Outcome

Outcome is the leading provider of strategies and solutions designed to meet the unique needs of the post-approval market. The Company focuses on program strategy and the practical deployment of registries, Phase IV studies, and risk management programs, including the application of state-of-the-art technology to better achieve the unique goals and requirements of the post-approval phase.Outcome's...

Endologix

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a leading cause of death in the United States and it ...

Endologix® Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge...

Loma Vista Medical

Headquartered in Silicon Valley (Burlingame, California.), Loma Vista Medical is a venture capital-funded medical device company dedicated to developing the world’s highest performing balloons for Balloon Aortic Valvuloplasty (BAV) and Transcatheter Aortic Valve Implantation (TAVI). Its pioneering mission is to commercialize products that are an indis...

Abt Associates Clinical Trials

Abt Associates Clinical Trials (AACT) is a full-service Contract Research Organization dedicated to serving the pharmaceutical, biotechnology, and medical device industries. AACT works with our clients to determine the safety and efficacy of their drugs, biologics, and devices supporting the process of obtaining FDA and other regulatory approvals. In the pre-approval phases, we offer our clients a...

Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enl...

Axonyx Incorporated

AXYX is engaged in the business of identifying and acquiring novel post-discovery central nervous system (CNS) drug candidates to advance through clinical development towards regulatory approval and acquiring patent rights and developing CNS pharmaceutical compounds.

JenaValve Technology

JenaValve Technology is a medical device company focused on developing transcatheter valve implantation systems to treat patients suffering from aortic valve disease. The company has transcatheter aortic valve implantation (TAVI) systems for both transapical and transfemoral approaches to address the needs of the cardiac surgeon and cardiologist, re...

SYMFO (USA) Inc.

Symfo is a fast-growing international organization that has developed straightforward and affordable electronic data collection technologies used in clinical trials, post-approval studies and consumer product studies.The Symfo Company was founded in 2000.

CardioLogical Solutions

Privately held CardioLogical Solutions is an emerging medical technology company focused on developing novel accessory devices for interventional cardiology procedures. For example, the recent emergence of transcatheter aortic valve replacement (TAVR) therapies has created a critical need for non-surgical, large-hole (>12 Fr) access and closure technologie...

Post Foods, LLC

Post Foods, LLC, a subsidiary of Ralcorp Holdings, is the manufacturer of iconic ready-to-eat cereal brands including Honey Bunches of Oats, Pebbles, Grape-Nuts, Shredded Wheat, Honeycomb, Post Selects, Trail Mix Crunch, and other great tasting cereals. For more information, please visit www.postcereals.com.

Pipex

Pipex Pharmaceuticals, Inc. (“Pipex”) (OTC: BB: PPEX) is a development-stage, specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neurologic and autoimmune diseases. Our strategy is to exclusively in-license proprietary, clinical-stage drug candidates that have demonstrated clinical efficacy and to complete the further clinical testi...

Boston Biomedical Associates

Boston Biomedical Associates has extensive expertise in guiding companies through the regulatory approval process, as well as post market activities (e.g. MDR, vigilance reporting). This expertise includes supporting domestic and international regulatory approvals, customizing Quality Systems to meet the needs of the regulations as well as the client. BBA ...

The Huffington Post

The Huffington Post is a Pulitzer Prize-winning source of breaking news, features, and entertainment, as well as a highly engaged community for opinion and conversation. The Huffington Post has 50 million monthly unique visitors (comScore November, 2012) posting more than 8 million comments each month. The site has more than 40,000 bloggers -- from politic...

ATS Medical Incorporated

ATS Medical is a leading medical device manufacturer specializing in mechanical heart valves, aortic valve graft prostheses, and related cardiovascular accessories. Located in Minneapolis, Minnesota, ATS is an international company with product sales in more than 40 countries across the globe, and superior product performance in over 50,000 patient implants. The ATS Open Pivot® Heart Valve has...


More From BioPortfolio on "ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks